Precision medicine: What the future holds

President Barack Obama recently announced a landmark Precision Medicine Initiative, a proposed $215 million investment to advance precision or personalized medicine and use genomics to customize patient treatment.

To learn more about the latest developments and breakthroughs in precision medicine, its vast potential and the regulatory implications, FierceHealthcare spoke with Gregory R. Weidner, M.D., medical director of primary care innovation and proactive health at Carolinas HealthCare System, an innovative network of more than 900 locations including academic medical centers, hospitals, physician practices, surgical and rehabilitation centers and other facilities throughout North and South Carolina. 

With a background in quality, medical informatics and technology, Weidner is working with his team to design and develop new models of care delivery that leverage team-based, technology-enabled, person-centered care and that promote patient engagement and empowerment.

In an exclusive interview with FierceHealthcare, Weidner shared his insights into what healthcare leaders across diverse types of organizations should know about the emerging world of precision medicine.

Read the full interview

Suggested Articles

Hospital system second quarter earnings illustrated just how pivotal a $175 billion provider relief fund was to offsetting major COVID-19 loss

Medicare Part D plans largely design their formularies to encourage use of generics, despite some criticism to the contrary, a new study shows.

Federal health officials released a proposed rule late Monday for 2021 Medicare payment rates and changes to the Merit-based Incentive Payment System.